Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
MEDUSA Links Death Rates to Drug Mechanisms
2026-08-25
Honeywell and colleagues introduce MEDUSA, a simulation-assisted framework that separates drug-treated cell growth from cell death in functional genomic screens. Applied to DNA damage, the method reveals that p53 loss redirects cells from apoptosis toward a respiration-dependent nonapoptotic death program, offering a more precise way to identify genetic determinants of drug lethality.
-
Chemistry of Silybin: Structure, Separation, and Derivatives
2026-08-25
Křen and colleagues’ review reconstructs more than five decades of silybin chemistry, with particular emphasis on absolute stereochemical assignment, separation of silybin A and B, and derivative synthesis. Its practical importance is that it distinguishes the defined flavonolignan from the chemically heterogeneous silymarin mixture, improving the interpretation of analytical and biological experiments.
-
Cy5 RNA labeling kit: Probe Workflow Guide
2026-08-24
Build fluorescent RNA probes by T7 transcription while tuning Cy5-UTP substitution to balance signal and transcript yield. This practical guide connects probe preparation with spatial hybridization, Northern analysis, and fluorescence tracking in RNA-delivery studies.
-
Mdivi-1 Workflows for DRP1 and Mitochondrial Fission
2026-08-24
Mdivi-1 enables acute, cell-permeable suppression of DRP1-dependent mitochondrial fission for apoptosis assays, mitochondrial dynamics research, and ischemic-retina models. This practical guide connects dosing and imaging workflows with the emerging extracellular-matrix-to-mitochondria signaling framework.
-
Indole-3-pyruvic acid: Experimental Workflows
2026-08-23
Indole-3-pyruvic acid connects plant auxin biosynthesis, fungal metabolite tracing, and mammalian AhR studies in one versatile experimental framework. This guide translates its pathway biology into practical assay design, control selection, and troubleshooting strategies.
-
Tiamulin: Applied Ribosome and Inflammation Workflows
2026-08-22
Tiamulin (Thiamutilin) combines strain-focused antibacterial activity with a researchable anti-inflammatory profile, making it useful for ribosome, veterinary infection, and cell-signaling studies. This workflow-led guide covers stock preparation, assay controls, resistance surveillance, exposure benchmarks, and troubleshooting.
-
CTOP in Brain-to-Spinal Opioid Research
2026-08-22
CTOP is a selective μ-opioid receptor antagonist for testing receptor dependence in opioid-induced hypersensitivity and tolerance. This article connects CTOP-based perturbation logic with the brain-to-spinal circuit revealed by Yin et al., helping researchers design more discriminating pain mechanism assays.
-
Prestained Protein Marker: Triple Color 10–250 kDa
2026-08-21
The Prestained Protein Marker is a Triple color protein ladder for visible SDS-PAGE separation control and Western blot protein size verification. F4005 combines recombinant, covalently dyed standards with an EDTA-free formulation for Phosbind SDS-PAGE and fluorescent membrane imaging workflows.
-
CTOP: Decoding Brain–Spinal Opioid Hypersensitivity
2026-08-20
A translational framework for using CTOP to test μ-opioid receptor dependence in the brain-to-spinal circuits that regulate opioid-induced mechanical hypersensitivity and analgesic tolerance.
-
CBX2, Interferon Signaling, and Tumor Immunogenicity
2026-08-20
The PNAS study identifies a noncanonical CBX2–RACK1–HDAC1 corepressor complex that suppresses interferon-stimulated genes and reduces tumor immunogenicity independently of canonical PRC activity. Its genetic, mechanistic, and tumor-model evidence positions CBX2 as a potential immunotherapy biomarker and a regulator of epigenetic immune evasion.
-
ZCL278: Selective Cdc42 Inhibitor Workflows
2026-08-19
ZCL278 is a selective Cdc42 inhibitor for connecting biochemical GTPase control with measurable changes in cell migration, neuronal morphology, and fibroblast behavior. This workflow-focused guide shows how to prepare the compound, build dose and time courses, pair motility assays with pathway readouts, and interpret findings alongside emerging Cdc42–β-catenin fibrosis biology.
-
NU7441 (KU-57788) Workflow for DNA-PK Studies
2026-08-19
NU7441 (KU-57788) is a potent ATP-site DNA-PK inhibitor for dissecting DNA repair, chemosensitization, and cell-cycle responses. This practical guide connects validated oncology workflows with a carefully bounded assay strategy for studying cytosolic DNA and TDP-43 homeostasis.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-08-18
The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit enables tunable fluorescent RNA probe synthesis for in situ hybridization and Northern blot workflows. This guide connects probe design with lessons from ROS-responsive mRNA delivery research while clarifying what fluorescence can—and cannot—prove.
-
Latrunculin B as a Temporal Actin Perturbation Tool
2026-08-18
Latrunculin B is more than an actin polymerization inhibitor: its transient pharmacology can reveal whether a cellular process truly depends on filament assembly. This article connects molecular mechanism, assay timing, and the Wang et al. GCRV entry study to improve interpretation of cytoskeletal experiments.
-
Pepstatin A: A Practical Aspartic Protease Workflow
2026-08-17
Pepstatin A is a versatile aspartic protease inhibitor for testing cathepsin D-dependent autophagy-lysosomal function, viral protein processing, and osteoclast biology. This workflow translates a recent ischemia/reperfusion study into practical assay design, dosing, controls, and troubleshooting decisions.